Trends in clinical outcomes and long-term survival after robotic gastrectomy for gastric cancer: a single high-volume center experience of consecutive 2000 patients

2021 ◽  
Author(s):  
Seohee Choi ◽  
Jeong Ho Song ◽  
Sejin Lee ◽  
Minah Cho ◽  
Yoo Min Kim ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Clinical Outcomes ◽  
High Volume ◽  
Robotic Gastrectomy ◽  
Term Survival ◽  
Long Term Survival ◽  
High Volume Center

Analysis of Long-Term Survival Following Transcatheter Aortic Valve Implantation from a Single High-Volume Center

2015 ◽  
Vol 116 (2) ◽  
pp. 256-263 ◽  
Author(s):  
Ricardo O. Escárcega ◽  
Michael J. Lipinski ◽  
Nevin C. Baker ◽  
Marco A. Magalhaes ◽  
Sa'ar Minha ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
High Volume ◽  
Term Survival ◽  
Long Term Survival ◽  
Transcatheter Aortic Valve ◽  
High Volume Center ◽  
Aortic Valve Implantation ◽  
Valve Implantation

scholarly journals Robotic Techniques in Esophagogastric Cancer Surgery: An Assessment of Short- and Long-Term Clinical Outcomes

2021 ◽  
Author(s):  
Sivesh K. Kamarajah ◽  
Ewen A. Griffiths ◽  
Alexander W. Phillips ◽  
Jelle Ruurda ◽  
Richard van Hillegersberg ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Robotic Surgery ◽  
Open Surgery ◽  
High Volume ◽  
The United States ◽  
Cancer Surgery ◽  
Term Survival ◽  
Long Term Survival ◽  
Esophagogastric Cancer

Abstract Background Robotic esophagogastric cancer surgery is gaining widespread adoption. This population-based cohort study aimed to compare rates of textbook outcomes (TOs) and survival from robotic minimally invasive techniques for esophagogastric cancer. Methods Data from the United States National Cancer Database (NCDB) (2010–2017) were used to identify patients with non-metastatic esophageal or gastric cancer receiving open surgery (to the esophagus, n = 11,442; stomach, n = 22,183), laparoscopic surgery (to the esophagus [LAMIE], n = 4827; stomach [LAMIG], n = 6359), or robotic surgery (to the esophagus [RAMIE], n = 1657; stomach [RAMIG], n = 1718). The study defined TOs as 15 or more lymph nodes examined, margin-negative resections, hospital stay less than 21 days, no 30-day readmissions, and no 90-day mortalities. Multivariable logistic regression and Cox analyses were used to account for treatment selection bias. Results Patients receiving robotic surgery were more commonly treated in high-volume academic centers with advanced clinical T and N stage disease. From 2010 to 2017, TO rates increased for esophageal and gastric cancer treated via all surgical techniques. Compared with open surgery, significantly higher TO rates were associated with RAMIE (odds ratio [OR], 1.41; 95% confidence interval [CI], 1.27–1.58) and RAMIG (OR 1.30; 95% CI 1.17–1.45). For esophagectomy, long-term survival was associated with both TO (hazard ratio [HR 0.64, 95% CI 0.60–0.67) and RAMIE (HR 0.92; 95% CI 0.84–1.00). For gastrectomy, long-term survival was associated with TO (HR 0.58; 95% CI 0.56–0.60) and both LAMIG (HR 0.89; 95% CI 0.85–0.94) and RAMIG (HR 0.88; 95% CI 0.81–0.96). Subset analysis in high-volume centers confirmed similar findings. Conclusion Despite potentially adverse learning curve effects and more advanced tumor stages captured during the study period, both RAMIE and RAMIG performed in mostly high-volume centers were associated with improved TO and long-term survival. Therefore, consideration for wider adoption but a well-designed phase 3 randomized controlled trial (RCT) is required for a full evaluation of the benefits conferred by robotic techniques for esophageal and gastric cancers.

scholarly journals Long-Term Survival of Two Patients with Liver Metastases from Advanced Gastric Cancer Treated with Radiofrequency Ablation and Chemotherapy

2021 ◽  
pp. 67-72
Author(s):  
Sung Jin Oh
Keyword(s):  
Gastric Cancer ◽  
Radiofrequency Ablation ◽  
Liver Metastases ◽  
Advanced Gastric Cancer ◽  
Systemic Chemotherapy ◽  
Subtotal Gastrectomy ◽  
Hepatic Metastases ◽  
Term Survival ◽  
Long Term Survival

Liver metastasis from gastric cancer has a very poor prognosis. Herein, we present two cases of liver metastases (synchronous and metachronous) from advanced gastric cancer. In the first case, the patient underwent radical subtotal gastrectomy. Liver metastases occurred 6 months after surgery while the patient was receiving adjuvant chemotherapy, but two hepatic tumors were successfully removed by radiofrequency ablation (RFA). In the second case, liver metastases occurred 15 months after surgery for gastric cancer. The patient also received RFA for one hepatic tumor, and other suspicious metastatic tumors were treated with systemic chemotherapy. Although these case presentations are limited for the efficacy of RFA treatment with systemic chemotherapy for hepatic metastases from gastric cancer, our findings showed long-term survival (overall survival for 108 and 67 months, respectively) of the affected patients, without recurrence. Therefore, we suggest that RFA treatment with systemic chemotherapy could be an effective alternative treatment modality for hepatic metastases from gastric cancer.

scholarly journals Factors Affecting Long Term Survival for Metastatic Gastric Cancer Treated with Chemotherapy

2016 ◽  
Vol 16 (2) ◽  
pp. 97
Author(s):  
Seong Kyeong Lim ◽  
Kyoungwon Jung ◽  
Moo In Park ◽  
Jae Hyun Kim ◽  
Sung Eun Kim ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Metastatic Gastric Cancer ◽  
Term Survival ◽  
Long Term Survival ◽  
Factors Affecting

scholarly journals Nomograms for pre- and postoperative prediction of long-term survival for patients of proximal gastric cancer: A large-scale,single-centre retrospective study

2017 ◽  
Vol 28 ◽  
pp. iii47
Author(s):  
Changming Huang ◽  
Qi-Yue Chen ◽  
Zhi-Liang Hong ◽  
Chao-Hui Zheng ◽  
Ping Li ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Retrospective Study ◽  
Large Scale ◽  
Single Centre ◽  
Proximal Gastric Cancer ◽  
Term Survival ◽  
Long Term Survival
Sign in / Sign up

Export Citation Format

Share Document